SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Acutaas Chemicals Ltd

BSE: 543349 NSE: ACUTAAS ISIN: INE00FF01025
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Acutaas Chemicals Ltd belong to?
Acutaas Chemicals Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Acutaas Chemicals Ltd a good quality company?
Acutaas Chemicals Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Acutaas Chemicals Ltd undervalued or overvalued?
Acutaas Chemicals Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Acutaas Chemicals Ltd a good buy now?
Acutaas Chemicals Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd revenue growth is 44% for FY-2025 , which is above its 5 year CAGR of 32.8% , indicating faster growth.
Q.2 Gross Profit margin of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Gross profit margin which is the profit after deduction of direct costs, is 24% for FY-2025 , which is above its 5 year median of 20.2% , indicating increasing margins.
Q.3 Operating Profit Margin of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 22.75% for FY-2025 , which is above its 5 year median of 20.24% indicating increasing margins.
Q.4 Net Profit Margin of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Net Profit Margin is 16.12% for FY-2025 , is above with its 5 year median of 13.83%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 24 20.2
Operating Profit Margin 22.75 20.24
Net Profit Margin 16.12 13.83
Q.5 Return on Asset of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Return on Asset is 12.23%, which is in line with its 5 year historical median of 12.23%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Return on equity is 16.08% for FY-2025 , which is in line with its historical median of 16.08%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Return on capital employed is 19.99% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 13.5%, indicating value creation.
Q.8 Cash conversion cycle of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Cash conversion cycle is 87 days, above its historical median of 87 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.76 0.87
ROE 16.08 16.08
ROCE 19.99 20.67
Cash Conversion Cycle 87 days 87 days
Q.9 Debt to Equity ratio of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd Debt to cash flow from operations is 0.05 , which is at a healthy level, indicating the business is able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Acutaas Chemicals Ltd?
Promoters hold 32.66% of the Acutaas Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Acutaas Chemicals Ltd vs industry peers?
Acutaas Chemicals Ltd revenue CAGR is 32.80% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 989.8 137.1
Gross Profit 237.6 15.1
Operating Profit 225 16
Net Profit 160 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.76 0.8
ROE 16.08 8.91
ROCE 19.99 11.59
Cash Conversion Cycle (days) 86.6 76

Valuation & price assessment

Q.1 Stock return of Acutaas Chemicals Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 69.58% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - 69.6% 111.7%
Q.3 Valuation ratios of Acutaas Chemicals Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 67.13 53.88 40.28
Price to Book 12.82 7.32 2.77
Price to Sales 16.25 7.33 2.65
EV to EBITDA 45.81 34.98 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Pfizer
6. Wockhardt
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Acutaas Chemicals
10. Piramal Pharma
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×